All In MedTech

Device Trial Radar · NCT07449416

Ceribell Delirium Monitor Outcomes Pilot Study

Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 15, 2026

Primary completion

Oct 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Ceribell Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 4, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.

Conditions

  • Delirium in the Intensive Care Unit

Interventions

  • Ceribell Delirium Monitoring SystemDevice

    The Ceribell Delirium Monitor provides an assessment of delirium every 15 minutes during each EEG recording and provides a trend graph depicting the output of the algorithm. If delirium is detected, a CAM-ICU assessment will be performed to confirm the presence of delirium. The patient's care team will use the additional data provided by the Ceribell Delirium Monitor to inform decisions regarding alterations in the patient's delirium management.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants with Delirium Diagnosed Outside Routine Standard-of-Care AssessmentsTime frame: From ICU admission to ICU discharge (up to 7 days)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of California Irvine

    Irvine, California · Recruiting

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.